Medical Therapy of Glaucoma


The overwhelming majority of eye disease is treated with eye drops, and undefeated eye disease management needs a comprehensive understanding of topical ocular medical care. The mucous membrane cul-de-sac may be a distinctive pharmacokinetic surroundings and provides several challenges to effective topical medical care. The principles reviewed here are often applied to subsequent chapters managing every specific drug category. In choosing the best medication, practitioners ought to think about the properties of medicine (e.g., efficiency and efficacy), and also the best dosing formulation (e.g., solution, suspension, gel). The medical man ought to conjointly make sure that the patient receives education regarding the correct instillation of medicines, and also the importance of adhering to the prescribed programme. Finally, with continued changes in health care management and pharmaceutical developments, problems with generic versus branded medication area unit having AN increasing impact on chronic, topical eye disease medical care.

  • Ocular Medications
  • Adrenergic Agonists

Related Conference of Medical Therapy of Glaucoma

August 28-29, 2024

5th International Conference on Euro Ophthalmology and Eye Surgery

Aix-en-Provence, France
September 12-13, 2024

5th International Conference on Optometry

Paris, France
October 10-11, 2024

34th World Congress on Ophthalmology and Optometry

Madrid, Spain
October 10-11, 2024

10th Global Ophthalmology Meeting

Madrid, Spain
October 17-18, 2024

24th Global Ophthalmologists Annual Meeting

London, UK
February 24-25, 2025

9th World Congress on Eye and Vision

Madrid, Spain
March 17-18, 2025

39th European Ophthalmology Congress

Berlin, Germany
April 07-08, 2025

6th World congress on Ophthalmology and Optometry

Amsterdam, Netherlands
April 29-30, 2025

35th International Congress on Vision Science and Eye

Barcelona, Spain

Medical Therapy of Glaucoma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in